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Background/Aims
Gastroesophageal reflux disease is one of the most common and frequent chronic disease requiring considerable cost. We in-
vestigated the medical care costs in the erosive reflux disease (ERD) and non-erosive reflux disease (NERD).
Methods
The risk factors and the direct medical care costs were analyzed retrospectively in the ERD (178 patients) and NERD (183 pa-
tients) groups for a follow up period of 2 years.
Results
Logistic regression analysis showed that the ERD was more frequent in the groups of male gender, alcohol consumption, high-
er body mass index (≥25 kg/m
2), hiatal hernia, and higher triglyceride levels (≥150 mg/dL). The direct medical care costs 
per person for 2 years were found to be $384.8 (ERD) and $412.9 (NERD) without statistically significant differences (p =
0.364). However, 9.3% (17/183) of the NERD patients had visited the emergency room compared to 3.4% (6/178) of the ERD 
patients (p = 0.029). In addition, more NERD patients were hospitalized than ERD patients (p = 0.006), and because of the 
longer hospitalization period, the medical costs in NERD patients were higher than ERD patients (p = 0.038).
Conclusions
In spite of the different risk factors for ERD and NERD, total direct medical care costs were similar between the ERD and NERD 
group. However, more visits to emergency room and longer hospitalization period with more hospitalization costs in NERD pa-
tients account for the differences in medical service and usage distribution between the 2 groups. 
(J Neurogastroenterol Motil 2010;16:265-273)
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Introduction
Gastroesophageal reflux disease (GERD) is a common and 
well-known digestive disorder and it often leads to troublesome 
symptoms and/or complication such as heartburn and acid regur-
gitation caused by the reflux of stomach contents.
1 Based on the 
findings of esophago-gastro-duodenoscopy (EGD), patients with 
GERD can be subdivided into 2 categories: those with or without 
erosive reflux disease (ERD). Patients with ERD have identifi-
able mucosal breaks in the distal esophagus on EGD whereas the 
non-erosive reflux disease (NERD) patients show normal-appea-
rance of mucosa. Although the prevalence of GERD is different 
by the country or survey method, it is well known that 10%-20% 
of the Western population and 5% of the Asian experiences 
heartburn and/or acid regurgitation at least once a week.
2 The 
prevalence of GERD in Korea used to be similar or slightly lower 
than other Asian countries until recently, however it is increasing 
with rises in overweight and a shift from the Korean traditional 
diet to a westernized one.
In the past studies, NERD was considered as one of the light 
symptoms of GERD which would progress to ERD gradually, 
and it was expected to eventually develop to ERD.
3,4 However, 
recent studies showed treating NERD to be more difficult than 
ERD and the rarity in developing ERD from NERD, suggest-
ing ERD and NERD as different phenotypes with their own 
pathophysiological relevances and clinical characteristics.
5,6 Mo-
reover, Fass et al
7 reported that NERD patient was more likely to 
have heartburns induced by intraesophageal stimuli which were 
increased by psychological stresses and emotional perturbations. 
Therefore, we hypothesized that there would be a difference in 
the medical care costs between ERD and NERD in visits to a 
physician or medications.
8,9
Generally, the medical care costs consist of the direct costs 
and indirect costs. The direct costs are caused by the medical 
products or services such as visits to a physician, diagnostic work-
up, medication or hospitalization. The indirect costs are accom-
panied by reduced productivity of patient by disease and the ab-
sence as the expenses ‘indirectly’ associated with consumption of 
medical products or services.
10,11 While some studies have been 
published on the medical care costs of GERD in comparisons be-
tween GERD and other digestive diseases,
12-14 there has been on-
ly one study published on the comparison of medical care costs 
between ERD and NERD so far.
15 Furthermore, there has been 
no paper on the medical care costs of GERD in Korea even 
though there have been a few with regard to the socioeconomic 
medical costs of obesity or depression.
16,17 In the present study, 
we investigated the total direct medical care costs of ERD and 
NERD as well as their associated risk factors.
Materials and Methods
1. Patients
The patients were selected from the group which had been 
studied in our previous published paper regarding ERD and 
NERD in 2009.
18 The patients, who visited and underwent up-
per gastrointestinal endoscopic examinations by one gastro-
enterologist (N.K) under impression of GERD because of reflux 
symptoms, were enrolled. The data regarding the GERD symp-
toms and clinical characteristic symptoms were collected through 
the survey before EGD. In that survey, the 7 symptoms of 
GERD were heartburn, acid regurgitation, chest pain, globlus 
sensation, cough, epigastric dyspepsia and epigastric soreness 
and there were questions about frequency and severity. In addi-
tion, the questionnaire about the following factors was also given 
to each subjects: (1) the presence of diabetes mellitus or hyper-
tension, (2) alcohol consumption and (3) smoking. The research 
assistants put the figures of the body mass index (BMI)
19 and bi-
ochemical test results, including triglyceride, high density lip-
oprotein, low density lipoprotein and Helicobacter pylori (H. pylo-
ri) tests such as Campylobacter like orga nism  test (CL O  test, 
Delta West, Bentley and Australia) or histology results. Since 
then, all study subjects with GERD symptoms underwent upper 
gastrointestinal endoscopic examinations, which were performed 
by one gastroenterologist (N.K) with 20 years of endoscopy expe-
rience and the endoscopic findings of ERD patients were classi-
fied using the Los Angeles classification (LA grades as A to D).
20 
Among the patients with no mucosal breaks on EGD, the pa-
tients who were positive for ambulatory 24-hour esophageal pH 
monitoring and/or acid perfusion test were defined as NERD. A 
positive test result for the ambulatory 24-hour esophageal pH mon-
itoring was determined when an acid exposure were over 4.2% of 
the total time (pH < 4) or a positive symptom index (> 50%).
18 A 
positive test of the acid perfusion test was determined when the 
pain or discomfort similar to the symptoms of GERD occurred 
with the instillation of 0.1 N HCl up to 70 mL and disappear af-
ter the acid solution replacement with 0.9% of normal saline 
solution. This procedure was repeated in order to confirm wheth-
er the test results were reliable.
18 Exclusion criteria included a Medical Care Costs of GERD in Korea
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Table 1. Comparison of Clinical Characteristics Between Erosive Reflux Disease and Non-Erosive Reflux Disease
Variable ERD (n = 178) NERD (n = 183) p-value
Age (mean ± SD, yr)   54.8 ± 14.0   53.5 ± 13.0 0.176
Male (n [%])   120 (67.4)     78 (39.9) 0.000
Alcohol use (n [%])     93 (50.9)     53 (29.8) 0.000
Current smoker (n [%])     55 (31.0)     29 (16.0) 0.001
Diabetes mellitus (n [%])     10 (5.5)     12 (6.3) 0.755
Hypertension (n [%])     50 (28.0)     33 (17.8) 0.027
H. pylori (n [%])
a     23 (46.9)     22 (51.2) 0.686
Hiatal hernia (n [%])     40 (22.7)    6.0 (3.4) 0.000
BMI (mean ± SD, kg/m
2)   24.5 ± 3.0   23.4 ± 3.1 0.386
   ≥ 25 (n [%])      81 (45.7)     65 (35.3) 0.018
   23-24.9 (n [%])      56 (31.4)     49 (26.9)
   < 23 (n [%])      41 (22.9)     69 (37.7)
Triglyceride (mean ± SD, mg/dL)    161 ± 88    115 ± 52 0.001
   ≥ 150 (n [%])     91 (51.4)     43 (23.7)
HDL (mean ± SD, mg/dL)      52 ± 12      56 ± 14 0.230
   < 40 (men) < 50 (women) (n [%])     46 (26.1)     41 (22.4)
LDL (mean ± SD, mg/dL) 113.0 ± 28.9 112.0 ± 30.5 0.865
aThe test was performed in 49 in ERD and 43 in NERD, respectively.
ERD, erosive reflux disease; NERD, non-erosive reflux disease; H. pylori, Helicobacter pylori; BMI, body mass index; HDL, high density lipoprotein; LDL, low density
lipoprotein.
Bold style indicates statistical significance.
history of gastrointestinal surgery or systemic disease requiring 
chronic medication (except hypertension and diabetes mellitus). 
And if subjects were diagnosed as gastric ulcer, duodenal ulcer or 
gastroduodenal cancer by EGD, none of them were included in 
our study. The present study was performed in 178 ERD pa-
tients and 183 NERD patients from May 2003 through August 
2006, which had been collected in the previous study.
18 However, 
27 from 205 ERD patients and 17 from 200 NERD patients 
who had been enrolled in the previous study
18 were excluded in 
the present study mostly because the follow-up was not under-
gone up to 2 years. This study was approved by the Institutional 
Review Board of Seoul National University Bundang Hospital.
2. Study protocol
The medical costs of health resources were calculated includ-
ing visits to a physician, diagnostic tests, medications, visits to 
emergency room and hospitalization for a period of 2 years since 
the first hospital visit for GERD symptoms. All of the enrolled 
patients had GERD symptoms and took proton pump inhibitors 
(PPIs). The diagnostic costs include expenses for the EGD, am-
bulatory 24-hour esophageal pH monitoring and esophageal 
manometry with acid perfusion test. The medication costs were 
restricted to the PPIs, H2-blockers, prokinetics and antacids (or 
sucralfate), the key drugs for GERD treatment. The costs caused 
by visits to emergency room and hospitalization were included 
when they were related to GERD. The unrelated or indirect 
medical care costs were excluded. The costs of drugs were de-
fined by the price of notice of Ministry of Health & Welfare. 
Other medical care costs were calculated based on medical in-
surance costs of Seoul National University Bundang Hospital.
3. Statistical methods
Categorical variables were analyzed with the χ
2 test or 
Fisher’s exact test, and continuous variables with Student’s t test 
or Mann-Whitney U test. All continuous variables including 
costs were presented as mean ± SD, and the proportions were 
expressed as numbers. A p-value of < 0.05 was considered stat-
istically significant. All analyses were performed with SPSS stat-
istical software package (SPSS 15.0 for Windows, SPSS Inc, 
Chicago, IL, USA).
Results
1. Patients characteristics
The ERD (LA-A 127 [71.3%], LA-B 43 [24.2%] and 
LA-C 8 [4.5%]) was diagnosed on 178 of the 361 patients by 
EGD. The remaining 183 patients with GERD symptoms and P y o u n g  J u  S e o ,  e t  a l
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Table 3. Comparison of Medical Care Costs Between Erosive Reflux Disease and Non-erosive Reflux Disease During 2 Years
Cost item ERD (n = 178) NERD (n = 183) p-value
Visits to a physician ($/person)
a   76.4 ± 53.4 67.53 ± 43.6 0.085
Diagnostic tests ($/person) 110.3 ± 78.6 123.7 ± 43.6 0.088
Medications ($/person) 191.7 ± 152.4 182.0 ± 188.0 0.637
      PPIs ($/person) 135.3 ± 109.0 125.9 ± 124.9 0.521
      H2-blockers ($/person)   32.5 ± 23.1   35.6 ± 48.0 0.706
      Prokinetics ($/person)   22.4 ± 26.4   19.6 ± 26.1 0.313
      Antacids or sucralfate ($/person)   1.62 ± 4.4     0.9 ± 2.82 0.061
No. of patients visiting emergency room       n = 6        n = 17 0.029
      Emergency room costs ($/person) 102.0 ± 62.7   81.0 ± 18.1 0.817
No. of patients with hospitalization        n = 2       n = 13 0.006
      Hospitalization costs ($/person) 213.9 ± 31.3 457.3 ± 175.3 0.038
Total direct costs ($/person) 384.8 ± 248.4 412.9 ± 287.1 0.364
aExchange rate of Korean currency to US dollar is 1,250 Won/US dollar ($).
ERD, erosive reflux disease; NERD, non-erosive reflux disease; PPIs, proton pump inhibitors. 
Bold style indicates statistical significance.
Table 2. Multivariate Logistic Regression Analysis for Characte-
ristics of the Subjects
Variable OR
a 95% CI p-value
Male sex 4.3 1.3-14.4 0.018
Alcohol use 2.7 1.2-8.3 0.042
Current smoker 0.9 0.3-3.9 0.920
BMI ≥ 25 3.1 1.1-9.7 0.048
Hiatal hernia  5.0 1.1-22.3 0.035
  ≥ 1 cm
Triglyceride  4.5 1.7-11.6 0.002
  ≥ 150 mg/dL
aOdds ratio of erosive reflux disease over non-erosive reflux disease.
OR, odds ratio; CI, confidence interval; BMI, body mass index.
Bold style indicates statistical significance.
no ERD, showed positive response in the ambulatory 24-hour 
esophageal pH monitoring and/or the acid perfusion test. The 
clinical characteristics of patients with ERD and NERD are 
shown in Table 1. There was statistically no significant differ-
ences between the 2 groups regarding age. More male patients 
(67.4%) were found than females (32.6%) in the ERD, whereas 
more females (60.1%) were found than males (39.9%) in the 
NERD (p = 0.000). Risk factors of the ERD group include al-
cohol consumption, smoking, frequency of hiatal hernia, higher 
triglyceride (≥ 150 mg/dL) and higher BMI (≥ 25 kg/m
2). 
However, there was no significant difference in H. pylori in-
fection rate, high density lipoprotein and low density lipoprotein 
levels. Covariates showing the significant association in the χ
2 test 
were calculated using the multivariate logistic regression analysis. 
Altogether, ERD was more common in male (OR, 4.3; 95% CI, 
1.3-14.4), with alcohol history (OR, 2.7; 95% CI, 1.2-8.3), higher 
BMI (≥ 25 kg/m
2; OR, 3.1; 95% CI, 1.1-9.7), patient with a 
hiatal hernia (OR, 5.0; 95% CI, 1.1-22.3), and higher trigly-
ceride levels (≥ 150 mg/dL; OR, 4.5; 95% CI, 1.7-11.6) (Table 
2).
2 .  C o m p a r i s o n  o f  d i r e c t  medical care costs between 
ERD and NERD group
Comparison of direct medical care costs per person for 2 
years of follow-up period between the ERD and NERD group 
are shown in Table 3. The total direct medical care costs per per-
son for 2 years were $384.8 (ERD) and $412.9 (NERD), re-
spectively (p = 0.364). With a closer look into the individual 
causal factors of the direct medical care costs, the costs related 
with visits to a physician were higher in the ERD group than in 
the NERD group but without significant difference. The medi-
cation costs were $191.7 in ERD, $182.0 in NERD, respectively 
and there was no statistical difference between the ERD and 
NERD group. The cost spent on PPI, the most important medi-
cine in GERD treatment, was higher in ERD than in NERD 
which was statistically not different. Seventeen of 183 NERD pa-
tients (9.3%) had emergency room visit history, which was higher 
than the 3.4% (6/178) of ERD patients (p = 0.029). However, 
there was no statistical difference in the average medical costs per 
each patient related with emergency room visit (p = 0.817). A 
total of 7.1% of the NERD patients (13/183) had history of hos-
pitalization, which was higher than 1.1% (2/178) of ERD pa-
tients (p = 0.006) (Fig. 1A). In addition, the mean duration of 
hospitalization was 8.0 days in the 13 NERD patients compared Medical Care Costs of GERD in Korea
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Figure 2. Distribution of total direct medical cost factors in erosive reflux disease (A) and non-erosive reflux disease group (B). Each factor 
contribution to total direct medical costs was calculated by percentage.
Figure 1. Hospitalization history (A) and hospitalization length (B) in the erosive reflux disease (ERD) and non-erosive reflux disease (NERD). 
The hospitalization history was found in the 2 of 178 ERD patients (1.1%) and 13 of 183 NERD patients (7.1%) (A). Mean hospitalization length 
was calculated in the 2 of ERD and 13 of NERD patients, respectively (B). 
to 2.5 days in ERD patients (Fig. 1B) and the average costs of 
hospitalization were higher in the NERD patients (p = 0.038) 
(Table 3). However, the total direct medical costs were not sig-
nificantly different between these 2 groups with slightly higher 
average fee in the NERD group. When we compared the ex-
pense factors of total direct medical care costs in the ERD and 
NERD, medications accounted for the major proportion and the 
second factor was the diagnostic expenses in both groups (Fig. 
2).
Discussion
It is widely accepted that the risk factors related to ERD and 
NERD are different. The prevalence of ERD is higher in the 
group of male gender, old age, with smoking, overweight or alco-
hol consumption but lower in the group with positive H. pylori in 
both the Western
21-24 and Eastern countries.
25,26 In contrast, 
NERD were more common in low BMI or female group.
26 
When we compared ERD and NERD, the prevalence of ERD 
was higher in the group of male gender, alcohol consumption, 
high BMI (≥ 25 kg/m
2), hiatal hernia or high triglyceride levels 
(≥ 150 mg/dL). In addition, it has been reported that the pro-
portion of patients with NERD responding to standard dose of 
PPI was around 20% to 30%, a lower response compared to the 
ERD group.
8,9 In the aspect of symptoms, the extraesophageal 
symptoms were more common in the NERD patients than the 
ERD patients
26,27 and double dose of PPI was often necessary for 
the symptom relief of the extraesophageal symptoms compared to 
the esophageal symptoms.
28-31
Based on this background, we hypothesized that total medi-P y o u n g  J u  S e o ,  e t  a l
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cal care costs caused by ERD or NERD could be different. On 
the contrary, the total direct medical care costs for 2 years were 
not significantly different between the ERD ($384.8) and 
NERD ($412.9) and the visiting numbers to physician were sim-
ilar in both groups, as 7.3 (ERD) and 6.3 (NERD), respectively. 
The total direct medical care costs of the first year were $331.3 
(ERD) and $352.2 (NERD), and the numbers of the outpatient 
visit were 6.1 (ERD) and 5.5 (NERD), respectively. The total 
direct m edical care costs of the second yea r were only $53.5 
(ERD) and $60.7 (NERD), and the average number of visit to a 
physician was around 1 time in both groups. The medical costs of 
the second year were small (13.9% for ERD, 14.7% for NERD 
group based on the total direct medical care costs) compared to 
the first year, suggesting that once the GERD symptoms have 
improved, then the patients preferred local clinics for on demand 
therapy instead of visiting specialists. As it was unfeasible to cal-
culate the expenses caused by medical source services with cur-
rent Korean medical system, the medical costs might have been 
underestimated in the present study.
After 4-week of standard PPI treatment, more than 50% of 
symptom was decreased in the 86.3% of ERD and 76.2% of the 
NERD patients. The refractory response was observed in 7.3% 
of ERD and 15.5% of NERD patients respectively, in the pre-
vious study.
18 Consistently, more NERD patients (36.5%) had 
extraesophageal symptoms (cough and globus sensation) com-
pared to ERD patients (10.1%).
18 Even though NERD patients 
had more refractory responses and extraesophageal symptoms, 
there was no statistical difference in the medical costs caused by 
hospital visit and PPI medication. This indicates that during the 
investigated period, ERD patients had continuous or intermittent 
medication prescriptions more often than NERD patients be-
cause ERD patients had more typical symptoms which were re-
sponsive to the medications than NERD patients. 
Although the hospitalizations in the ERD (2 patients, 1.1%) 
and NERD (13 patients, 7.1%) group were relatively few in 
number, the hospitalization fee per admitted person was sig-
nificantly higher in the NERD group and the hospitalization du-
rations in NERD patients were 3 times longer (average 8 days) 
than the 2 ERD patients (average 2.5 days), with statistically sig-
nificant difference (p = 0.040). There was not much difference 
in the medical costs, however visits to emergency room were more 
frequent in NERD (17/183, 9.3%) than ERD (6/178, 3.4%) pa-
tients (p = 0.029). The NERD patients with more histories of 
visits to emergency room and hospitalization might be related to 
the fact that NERD patients are less responsive to PPI medi-
cation and present with more frequent refractory responses than 
ERD patients. 
The present study showed that the first major causal factor of 
the total direct medical care costs was the medication fee in both 
subtypes of GERD. The expense proportion of medications was 
49.8% (ERD) and 44.1% (NERD) respectively. These results 
are consistent with other reports on the medical care costs for 
GERD in USA or European countries.
32-34 On demand therapy 
is known to be effective for the long term treatment of NERD
35 
whereas continuous maintenance therapy has been reported to be 
more effective in patients with ERD.
36,37 However, our previous 
study with similar study population has shown that the proportion 
of on demand therapy was similar in the ERD (47.6%) and 
NERD patients (41.6%). The relapse rates were found to be 
44.3% for patients with ERD and 43.2% for patients with 
NERD during a follow up period of 1 year.
18 Taken together, the 
high relapse rates and on demand therapy rates of ERD and 
NERD might have contributed to the high cost of medications in 
both groups of the present study.
The present study, which analyzed the direct medical care 
costs between NERD and ERD in Korea for the first time, has 
several limitations. First, our analysis has been based on the med-
ical care costs happened in the Seoul National University 
Bundang Hospital alone which is because the medical care cost 
data in other hospitals or primary care units are not available un-
der current Korean medical system. However, most of the 
GERD patients in our study reported that they had visited local 
clinics for on demand therapy. Therefore, we have reasoned that 
the major costs might have occurred in the Seoul National 
University Bundang Hospital. Secondly, since the direct medical 
care costs are mainly regulated by government in Korea, they are 
rather cheap compared to Western countries. The general 
GERD medical care costs in our study were lower than that in 
most studies based on European or American population.
11,15,38,39 
Third, it is possible that the patients with more severe symptom 
or refractory response to PPI might be included in NERD pa-
tients group because NERD patients were defined by the positive 
results on the ambulatory 24-hour esophageal pH monitoring 
and/or acid perfusion test. PPI test has become popular as one of 
the recent diagnostic methods for NERD but this modality is still 
under study and has to be defined better for a reliability. 
Therefore, we restricted the diagnosis of NERD to those who 
showed positivity on the ambulatory 24-hour esophageal pH 
monitoring and/or the acid perfusion test. In the future, further 
study is necessary to overcome this limitation of the present study Medical Care Costs of GERD in Korea
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in terms of selection bias.
In spite of these 3 limitations the present study is meaningful 
since it compared the total direct medical care costs between 
ERD and NERD for the first time in Korea as well as in Asia. 
In conclusion, the total direct medical care costs were similar 
in the ERD and NERD group in spite of the different risk fac-
tors for ERD and NERD. However, NERD patients visit to 
emergency room more often and have more hospitalization costs 
indicating that the medical service and usage distribution are dif-
ferent between the 2 groups. 
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